BOTHELL, Wash., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ:ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it has changed its name to LeonaBio, Inc. The name change aligns with the Company's transformative acquisition of rights to develop and commercialize lasofoxifene, a promising late-stage clinical asset for the potential treatment of metastatic breast cancer, currently ...

New name to reflect recent transformative acquisition of rights to Phase 3 program in metastatic breast cancer and commitment to continued leadership, resilience and innovationBOTHELL, Wash., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it has changed its name to LeonaBio, Inc. The name change aligns with the Company’s transfo ...

Core Viewpoint - ATHA Energy Corp. has announced the grant of 10,150,000 incentive stock options and 1,300,000 restricted share units to eligible participants under its equity incentive plan [1] Summary by Category Stock Options - The company granted a total of 10,150,000 incentive stock options to certain eligible participants, including directors and officers [1] - The vesting schedule for the options is structured as follows: one-third will vest on the date of issuance, one-third on the six-month anniversary, and the remaining one-third on the twelve-month anniversary of the issuance [1] Restricted Share Units - In addition to stock options, the company also granted 1,300,000 restricted share units to eligible participants under the same equity incentive plan [1]

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WHITE ROCK, BRITISH COLUMBIA / ACCESS Newswire / December 19, 2025 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena Gold" or the "Company") is pleased to announce that, further to its news releases of November 17, November 24, December 9, and December 15, 2025, the Company has closed the third and final tranche of its priv ...

Athira Pharma Inc. (NASDAQ:ATHA) stock is trading higher on Thursday, with a session volume of 57.29 million compared to the average volume of 30.94 thousand as per data from Benzinga Pro.Athira Pharma on Thursday agreed to acquire the rights for the development and commercialization of lasofoxifene, a clinical asset in a potentially registrational Phase 3 trial.The ongoing Phase 3 ELAINE-3 clinical trial is greater than 50% enrolled, with data expected in mid-2027.Athira has acquired an exclusive global li ...

PresentationHello, ladies and gentlemen. Thank you for standing by, and welcome to the Athira Pharma conference call. [Operator Instructions] Please be advised that today's conference call may be recorded. I would now like to hand the conference call over to Julie Rathbun, Head of Investor and Public Relations with Athira, please go ahead.Julie RathbunHead of Investor Relations Thank you, operator. Good morning, and welcome to the Athira Pharma conference call to discuss the transformative transactions anno ...

In a remarkable pivot, Athira Pharma has a deal to test a promising breast cancer drug and landed $90 million in upfront funding from investors. ...

Athira Pharma, Inc. (ATHA) shares surged 69.53 percent, gaining $2.88 to trade at $7.01 on Thursday, after the clinical-stage biopharmaceutical company announced an agreement to acquire global development and commercialization rights to lasofoxifene, a Phase 3 ready asset for metastatic breast cancer. The stock was trading at $7.01, up sharply from a previous close of $4.14 on the Nasdaq. Shares opened at $7.22 and moved within a day's range of $6.77 to $8.35. Trading volume spiked to about 53.19 million s ...

US stock market jumps today: U.S. stocks moved higher on Thursday as Wall Street reacted to softer-than-expected The delayed November Consumer Price Index (CPI) showed inflation cooling more than economists had forecast. That data, combined with upbeat corporate earnings and resilient labor market signals, lifted investor sentiment after several rough sessions for equities. Semiconductor stocks, which had been under pressure earlier in the week, led the rebound as Micron’s results exceeded expectations and ...

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 400 points on Thursday.The Dow traded up 0.84% to 48,289.58 while the NASDAQ jumped 1.53% to 23,040.25. The S&P 500 also rose, gaining, 1.09% to 6,794.36.Check This Out: Wall Street’s Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend YieldsLeading and Lagging SectorsConsumer discretionary shares rose by 1.6% on Thursday.In trading on Thursday, energy stocks fell by 0.8%.Top HeadlineAccenture ( ...